Dunhill Financial, LLC Xencor Inc Transaction History
Dunhill Financial, LLC
- $409 Billion
- Q4 2025
A detailed history of Dunhill Financial, LLC transactions in Xencor Inc stock. As of the latest transaction made, Dunhill Financial, LLC holds 1 shares of XNCR stock, worth $14. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$14% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XNCR
# of Institutions
221Shares Held
80.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$166 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.7MShares$159 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.17MShares$107 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.22MShares$92.9 Million0.98% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$91.7 Million5.41% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $891M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...